Page last updated: 2024-09-03

cgp 52432 and Chronic Disease

cgp 52432 has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aiyar, J; Anker, N; Belley, M; Bristow, L; Campbell, B; Cohen, C; Park, KT; Ren, K; Stearns, B; Urban, MO	1

Other Studies

1 other study(ies) available for cgp 52432 and Chronic Disease

Article	Year
Comparison of the antinociceptive profiles of gabapentin and 3-methylgabapentin in rat models of acute and persistent pain: implications for mechanism of action. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 313, Issue:3 Topics: Acetates; Acute Disease; Amines; Analgesics; Animals; Benzylamines; Chronic Disease; Cyclohexanecarboxylic Acids; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Male; Pain; Phosphinic Acids; Rats; Rats, Sprague-Dawley; Receptors, GABA-B	2005

Article

Year

Comparison of the antinociceptive profiles of gabapentin and 3-methylgabapentin in rat models of acute and persistent pain: implications for mechanism of action.

The Journal of pharmacology and experimental therapeutics, 2005, Volume: 313, Issue:3

Topics: Acetates; Acute Disease; Amines; Analgesics; Animals; Benzylamines; Chronic Disease; Cyclohexanecarboxylic Acids; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Male; Pain; Phosphinic Acids; Rats; Rats, Sprague-Dawley; Receptors, GABA-B

2005